Commercial Translation leader
Associate Professor, Biomedical Informatics, School of Medicine
Codirector, Center for Commercial Applications of Healthcare Data
Codirector, Clinical and Translational Science Institute, Innovation Core
Associate Director, Center for Medical Innovation
Associate Professor, Bioengineering, Swanson School of Engineering
Associate Professor, Plastic Surgery, School of Medicine
Faculty, McGowan Institute for Regenerative Medicine
Leading Commercial Translation across Pitt’s six health sciences schools to advance basic research toward market-focused solutions.
Donald P. Taylor, PhD, MBA, CLP, is Assistant Vice Chancellor for Health Sciences Translation, Executive Director, sciVelo, Co-director, Clinical and Translational Science Institute Innovation Core, Associate Director, Center for Medical Innovation, Associate Professor of Biomedical Informatics and of Plastic Surgery, School of Medicine, and Associate Professor of Bioengineering, Swanson School of Engineering.
Dr. Taylor has more than 20 years of life sciences translational research and commercial translation experience. His current responsibilities include driving academic commercial translation across the six University of Pittsburgh Health Sciences schools (Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Health & Rehabilitation) to accelerate commercial translation of Pitt’s discoveries and inventions, grow corporate sponsored research, secure commercial translation grants, and help train the next generation of world-class commercial translation students, staff, and faculty. Dr. Taylor’s research spans translational scientific investigations into metastatic breast cancer latency and chronic wound healing as well as new methods for health sciences commercial translation. Dr. Taylor is currently a co-investigator on two NIH-funded U01 grants including the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center and co-investigator on an FDA-funded P50 grant to establish the Pennsylvania Pediatric Device Consortium. Prior to his academic career, Dr. Taylor served as Founder, Co-founder, Board Chairman, CEO, and Vice President across six life sciences companies – all of which have been acquired by companies including Hospira and IBM. Dr. Taylor holds a PhD in Bioengineering from the University of Pittsburgh.
PhD, Bioengineering, University of Pittsburgh, 2013
MBA, University of Pittsburgh, 2006
MS, Bioengineering, University of Pittsburgh, 2005
BS, Information Systems, Carnegie Mellon University, 1998
Associate Professor of Biomedical Informatics and of Plastic Surgery, School of Medicine, University of Pittsburgh, July 2016 – present
Faculty, McGowan Institute for Regenerative Medicine at UPMC, November 2014 – Present
Postdoctoral Research, Department of Pathology, University of Pittsburgh School of Medicine, 2014
Doctoral Research, Department of Bioengineering, University of Pittsburgh, 2011-2013
Graduate Research, Department of Bioengineering, University of Pittsburgh, 2003-2005
Founder & Executive Director, sciVelo, July 2016 – Present
Founder & Principal Consultant at bioStratica, LLC, February 2010 – June 2016
Founder & Business Advisor at healthStratica, December 2014 – June 2016
Adjunct Professor of Biomedical Engineering by Courtesy at Duquesne University, November 2014 – Present
Executive-in-Residence at Pittsburgh Life Sciences Greenhouse, June 2010 – June 2016
Vice President, Marketing & Corporate Development at Cellumen, January 2008 – August 2010
Cell-based assays (high content) and informatics for drug discovery and toxicology
Member Board of Directors, Sculptor Developmental Technologies at St. Clair Hospital, March 2005 – April 2008
Marketing Manager, Pharma/Biotech at Thermo Fisher Scientific, July 2006 – January 2008
Senior Director, Life Sciences at IBM, February 2004 – March 2006
Vice President, Business Development at SHP Data, 2001 – 2004
Co-founder, President & CEO at Net Health Systems, Inc., 1993 – 2001
Cell-Based Compositions, Cell-Based Bandage Devices And Systems And Methods Of Treatment Therewith, US Patent Application Filed Jan 28, 2016. US 14/772,501 (Wells, Yates, Taylor).